Recently, Steinauer et al. demonstrated that MTG16 regulates histone acetylation and chromatin accessibility of myeloid-specific enhancers to reduce expression of RARα target genes in human acute myeloid leukemia cells (81). The gene discussed is RARA; the disease is acute myeloid leukemia.